TY - JOUR AU - Zhou, Caicun AU - Manegold, Christian PY - 2011 TI - Chemotherapy of lung cancer: a global perspective of the role of ifosfamide JF - Translational Lung Cancer Research; Vol 1, No 1 (March 18, 2012): Translational Lung Cancer Research Y2 - 2011 KW - N2 - The oxazaphosphorine cytostatic ifosfamide (IFO) has been successfully integrated in the treatment of various hematological and solid tumors. The purpose of this review is to summarize the evidence for its use in lung cancer starting from basic data of preclinical studies followed by a global summary of the phase III and seminal phase II clinical studies. Global in double respect: first covering both the small cell as well as the non-small cell indications, and, second tracing those studies performed in Europe and the United States as well as those from Asian countries. UR - https://tlcr.amegroups.org/article/view/277